Activity and phenotypes of angiotensin-converting enzyme (ACE) in sarcoidosis with various organ involvement L. Francuzevica (Moscow, Russian Federation), A. Bobkov (Moscow, Russian Federation), L. Akulkina (Moscow, Russian Federation), M. Brovko (Moscow, Russian Federation), V. Sholomova (Moscow, Russian Federation), D. Konovalov (Moscow, Russian Federation), A. Yanakaewa (Moscow, Russian Federation), L. Samokhodskaya (Moscow, Russian Federation), T. Krasnova (Moscow, Russian Federation)
Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Disease area: Interstitial lung diseasesRating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Francuzevica (Moscow, Russian Federation), A. Bobkov (Moscow, Russian Federation), L. Akulkina (Moscow, Russian Federation), M. Brovko (Moscow, Russian Federation), V. Sholomova (Moscow, Russian Federation), D. Konovalov (Moscow, Russian Federation), A. Yanakaewa (Moscow, Russian Federation), L. Samokhodskaya (Moscow, Russian Federation), T. Krasnova (Moscow, Russian Federation). Activity and phenotypes of angiotensin-converting enzyme (ACE) in sarcoidosis with various organ involvement. 1087
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Clinical significance of angiotensin converting enzyme (ACE) activity in sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 384s Year: 2001
Serum angiotensin converting enzyme (ACE) as additional clinical markers of activity of pulmonary and extra-pulmonary locations of sarcoidosis Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011
Angiotensin-converting enzyme inhibitor use and pneumonia risk in a general population Source: Eur Respir J 2006; 27: 1217-1222 Year: 2006
Correlation between angiotensin-converting enzyme (ACE) gene polymorphism and exercise performance in COPD patients Source: Annual Congress 2010 - Exercise in COPD Year: 2010
Impact of statins, angiotensin-converting enzyme inhibitors (ACEI), and angiotensin receptor blockers (ARBS) on reducing COPD morbidity Source: Annual Congress 2009 - Treatment of airways disease Year: 2009
Angiotensin-converting enzyme 2 expression is not induced by the renin–angiotensin system in the lung Source: ERJ Open Res, 6 (4) 00402-2020; 10.1183/23120541.00402-2020 Year: 2020
Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia Source: Eur Respir J 2008; 31: 611-617 Year: 2008
Circulating d-Dimer lysozyme and angiotensin-converting enzyme in active sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 196s Year: 2001
Bronchial reactivity for histamine and serum angiotensin converting enzyme (sACE) activity in sarcoidosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 669s Year: 2004
Effect of angiotensin converting enzyme (ACE) gene polymorphism on diaphragmatic endurance in neonates Source: Annual Congress 2008 - Neonatal intensive care: ventilation and beyond Year: 2008
Alteration in angiotensin-converting enzyme 2 by PM1 during the development of emphysema in rats Source: ERJ Open Res, 6 (4) 00174-2020; 10.1183/23120541.00174-2020 Year: 2020
No association of angiotensin I-converting enzyme gene polymorphism and pulmonary function in cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 173s Year: 2003
Value of serum angiotensin converting enzyme (SACE) level in the assessment of lung parenchyma impairment in newly diagnosed sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 45s Year: 2003
Genotype-corrected reference values for serum angiotensin-converting enzyme Source: Eur Respir J 2006; 28: 1085-1091 Year: 2006
Impact of statins, angiotensin-converting enzyme inhibitors(ACEI), and angiotensin receptor blockers (ARBs) on reducing COPD morbidity Source: Annual Congress 2010 - COPD: management Year: 2010
ACE I/D but not AGT (-6)A/G polymorphism is a risk factor for mortality in ARDS Source: Eur Respir J 2007; 29: 482-488 Year: 2007
Etiology specific reductions in pulmonary endothelial angiotensin converting enzyme activity in patients with PAH Source: Eur Respir J 2006; 28: Suppl. 50, 658s Year: 2006
Serum angiotensin-converting enzyme activity in lymphangioleiomyomatosis Source: International Congress 2015 – IIPs: orphan Year: 2015
Angiotensin-converting enzyme insertion/deletion gene polymorphism and interstitial pulmonary fibrosis in Iranian population Source: Eur Respir J 2005; 26: Suppl. 49, 542s Year: 2005
The influence of angiotensin-converting enzyme (ACE) genotype on the development of severe perinatal asphyxia in the neonates Source: Annual Congress 2011 - Issues in paediatric and neonatal intensive care Year: 2011